RPL3L
Ribosomal protein uL3-like
Also known as: RL3L_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92901
- Gene
- RPL3L
- Ensembl
- ENSG00000140986
- Chromosome
- 16
- Canonical length
- 407 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins
- Subcellular location
- Nuclear speckles
OverviewNCBI Gene
This gene encodes a protein that shares sequence similarity with ribosomal protein L3. The protein belongs to the L3P family of ribosomal proteins. Unlike the ubiquitous expression of ribosomal protein genes, this gene has a tissue-specific pattern of expression, with the highest levels of expression in skeletal muscle and heart. It is not currently known whether the encoded protein is a functional ribosomal protein or whether it has evolved a function that is independent of the ribosome. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
407 residues, UniProt reviewed canonical sequence.
>Q92901|RPL3L
1 MSHRKFSAPR HGHLGFLPHK RSHRHRGKVK TWPRDDPSQP VHLTAFLGYK AGMTHTLREV
61 HRPGLKISKR EEVEAVTIVE TPPLVVVGVV GYVATPRGLR SFKTIFAEHL SDECRRRFYK
121 DWHKSKKKAF TKACKRWRDT DGKKQLQKDF AAMKKYCKVI RVIVHTQMKL LPFRQKKAHI
181 MEIQLNGGTV AEKVAWAQAR LEKQVPVHSV FSQSEVIDVI AVTKGRGVKG VTSRWHTKKL
241 PRKTHKGLRK VACIGAWHPA RVGCSIARAG QKGYHHRTEL NKKIFRIGRG PHMEDGKLVK
301 NNASTSYDVT AKSITPLGGF PHYGEVNNDF VMLKGCIAGT KKRVITLRKS LLVHHSRQAV
361 ENIELKFIDT TSKFGHGRFQ TAQEKRAFMG PQKKHLEKET PETSGDLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RPL3L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 884 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 884 nTPM
- tongue: 395 nTPM
- heart muscle: 166 nTPM
- pancreas: 11 nTPM
- esophagus: 8.2 nTPM
- salivary gland: 6.6 nTPM
Single-cell type
- myonuclei: 352 nCPM
- cardiomyocytes: 66 nCPM
- thymic myoid cells: 63 nCPM
- early spermatids: 39 nCPM
- differentiating spermatogonia: 32 nCPM
- late primary spermatocytes: 28 nCPM
Immune cell
- neutrophil: 1.2 nTPM
- basophil: 0.4 nTPM
- eosinophil: 0.4 nTPM
- memory B-cell: 0.4 nTPM
- naive B-cell: 0.4 nTPM
- plasmacytoid DC: 0.4 nTPM
Brain region
- cerebellum: 14 nTPM
- white matter: 13 nTPM
- basal ganglia: 12 nTPM
- cerebral cortex: 12 nTPM
- hypothalamus: 12 nTPM
- amygdala: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RPL3L.
Disease | AllUniProt
Conditions RPL3L is implicated in, by any mechanism.
- Cardiomyopathy, dilated, 2D (CMD2D) MIM:619371
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 139 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cardiomyopathy, dilated, 2D
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.61
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.69
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of myotube differentiation
- regulation of striated muscle tissue development
- translation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RPL3L as an antibody target. Whether an autoantibody or antibody against RPL3L could matter depends on whether native RPL3L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RPL3L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RPL3L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...